News

Zacks Investment Research on MSN13h
DTIL Gets FDA's Fast Track Tag for Hepatitis B Gene Therapy, Stock Up
Shares of Precision BioSciences DTIL rallied 23.8% on Tuesday after the company’s announcement that the FDA has granted Fast ...
Verve Therapeutics: FDA Fast Track And Eli Lilly Partnership Upgrade It To A 'Buy'
VERV’s VERVE-102 showed an impressive 69% LDL-C reduction in its early Phase 1b data. Click here to find out why I rate VERV ...
Zacks Investment Research on MSN8d
FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug
Allogene Therapeutics ALLO announced that the FDA has granted three fast track designations to its investigational ...
SynOx Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT)
SynOx Therapeutics Limited (“SynOx”), a late-stage clinical biopharmaceutical company developing of emactuzumab for Tenosynovial Giant Cell Tumours (TGCT), today announced that the United States Food ...
Arcturus Gets FDA Fast-Track Designation for Pandemic Influenza A H5N1 Vaccine
Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.
Precision BioSciences receives FDA fast track designation for PBGENE-HBV
Precision BioSciences (DTIL) announced that the FDA has granted fast track designation for PBGENE-HBV, the company’s lead wholly owned in vivo ...
Nasdaq9d
Allogene's ALLO-329 Granted Three FDA Fast Track Designations
has received three Fast Track Designations (FTD) from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with Lupus, Myositis and Scleroderma, "Receiving these ...